Johnson & Johnson insider trading

Bought

—

Sold

$71.5M

none on a 10b5-1 plan

Net

−$71.5M

Insiders

7

• Schmid Timothy

  EVP, WW Chair, MedTech

  −$3M

  Sep 02, 2026

  11,070 sh · $274.74

• Schmid Timothy

  EVP, WW Chair, MedTech

  −$6.2M

  Sep 02, 2026

  22,527 sh · $274.74

• Taubert Jennifer L

  EVP, WWC. Innovative Medicine

  −$4M

  Aug 17, 2026

  15,000 sh · $263.36

• Duato Joaquin

  CEO and Chairman of the Board · Director

  −$5.5M

  Aug 13, 2026

  20,976 sh · $262.00

• Duato Joaquin

  CEO and Chairman of the Board · Director

  −$26.7M

  Aug 13, 2026

  102,315 sh · $261.00

• Forminard Elizabeth

  EVP, Chief Legal Officer

  −$2.4M

  Aug 06, 2026

  9,344 sh · $257.76

• Forminard Elizabeth

  EVP, Chief Legal Officer

  −$1.7M

  Aug 06, 2026

  6,574 sh · $255.93

• Duato Joaquin

  CEO and Chairman of the Board · Director

  −$10.8M

  Aug 05, 2026

  41,957 sh · $258.06

• Duato Joaquin

  CEO and Chairman of the Board · Director

  −$1.7M

  Aug 05, 2026

  6,523 sh · $258.74

• Broadhurst Vanessa

  EVP, Global Corp Affairs

  −$5.8M

  Jul 20, 2026

  23,054 sh · $251.27

• Wengel Kathryn E

  EVP, Chief TO and Risk Officer

  −$2.4M

  Jun 11, 2026

  10,000 sh · $241.15

• Decker Robert J

  VP Corporate Controller

  −$1M

  Feb 27, 2026

  4,075 sh · $247.87

• Schmid Timothy

  EVP, WW Chair, MedTech

  −$324.8K

  Feb 20, 2026

  1,322 sh · $245.66

Largest purchase

+$257.7K of JNJ by Morikis John G (Director) on Nov 26, 2025.

Largest sale

−$22.5M of JNJ by Duato Joaquin (CEO and Chairman of the Board · Director) on Aug 22, 2025.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

New Brunswick, NJ

Incorporated in

NJ

Listed on

NYSE

SEC Central Index Key

0000200406

Previously filed as

JOHNSON & JOHNSON ET AL

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are JNJ insiders buying or selling?

Between Feb 20, 2026 and Sep 02, 2026, 7 Johnson & Johnson insiders made no open-market purchases and 13 sales worth $71.5M, a net sale of $71.5M.

How much JNJ stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 11 Johnson & Johnson insiders made 2 open-market purchases worth $404.9K and 27 sales worth $129.9M. In the four quarters to Jun 30, 2026: 1 purchase ($257.7K) and 23 sales ($125.8M). The largest purchase was Morikis John G buying $257.7K on Nov 26, 2025. The largest sale was Duato Joaquin selling $22.5M on Aug 22, 2025.

What was the largest recent JNJ insider trade?

Duato Joaquin (CEO and Chairman of the Board · Director) sold $26.7M of JNJ stock on Aug 13, 2026 at about $261.00 a share.

When did an insider last buy JNJ shares?

No open-market purchase by a Johnson & Johnson insider appears in the filings from Feb 20, 2026 to Sep 02, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Morikis John G buying $257.7K on Nov 26, 2025.

Where does JNJ insider trading data come from?

From the Form 4 filings Johnson & Johnson's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.